510(k) K920109
K920109 is an FDA 510(k) premarket notification submitted by Abbott Laboratories for the device "IMX INSULIN". The FDA issued a decision of Substantially Equivalent on May 7, 1992. The device falls under product code CFP (Radioimmunoassay, Immunoreactive Insulin), a Class I device regulated under 21 CFR 862.1405. Abbott Laboratories has 889 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 7, 1992
- Date Received
- Jan 10, 1992
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Radioimmunoassay, Immunoreactive Insulin
- Device Class
- Class I
- Regulation Number
- 862.1405
- Review Panel
- CH
- Submission Type
- 510(k) Exempt
Need the full FDA record for Abbott Laboratories? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.